Ignite Creation Date:
2024-05-06 @ 3:57 PM
Last Modification Date:
2024-10-26 @ 2:00 PM
Study NCT ID:
NCT04810793
Status:
COMPLETED
Last Update Posted:
2022-10-27
First Post:
2021-03-21
Brief Title:
The Study on the Selection of Time for Retreatment of Helicobacter Pylori After Eradication Failure
Sponsor:
Shandong University
Organization:
Shandong University
Study Overview
Official Title:
The Study on the Selection of Time for Retreatment of Helicobacter Pylori After Eradication Failure
Status:
COMPLETED
Status Verified Date:
2022-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The patients who accepted the quadruple eradication program of the helicobacter pylori but failed to eradicate helicobacter pylori will be assessed the most suitable re-eradication time of helicobacter pylori
Detailed Description:
Helicobacter pylori HP infection is a common global infectious disease which is an important cause of chronic gastritis peptic ulcer and gastric cancer
At present due to the non-standard Helicobacter pylori eradication program in clinical work poor patient compliance and other reasons the phenomenon of HP eradication treatment failure is more and more common However there is still no conclusion on the most appropriate time for remedial treatment in patients with Hp eradication failure
At present due to the non-standard Helicobacter pylori eradication program in clinical work poor patient compliance and other reasons the phenomenon of HP eradication treatment failure is more and more common However there is still no conclusion on the most appropriate time for remedial treatment in patients with Hp eradication failure
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None